Golden
ImStar Therapeutics

ImStar Therapeutics

ImStar Therapeutics is company developing treatments for ALS, dementia, and other neurodegenerative diseases.

All edits

Edits on 2 Jun 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 2 Jun 2019 4:59 am
Edits made to:
Article (+14/-14 characters)

Article

ImStar Therapeutics is a biotechnology company developing treatments for neurodegenerative diseases. The company is headquartered in Vancouver, British Columbia, Canada and was founded in 2012 by Daniel WattierDaniel Wattier and Jean Pierre Julien.

Edits on 29 May 2019
Golden AI
Golden AI edited on 29 May 2019 1:21 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 2 Apr 2019
Dawson Sewell
Dawson Sewell edited on 2 Apr 2019 7:03 pm
Edits made to:
Infobox (+5 properties)
Further reading (+4 cells) (+197 characters)

Further reading

Title
Author
Link
Type

ImStar Therapeutics raises $1.8 million to research ALS treatment solutions | BetaKit

JESSICA GALANG

Web

Infobox

Date incorporated
2012
Edits on 21 Jan 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 Jan 2019 9:26 pm
Edits made to:
Infobox (+2/-2 properties)
Edits on 9 Jan 2019
Golden AI
Golden AI edited on 9 Jan 2019 9:59 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 14 Dec 2018
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 14 Dec 2018 10:16 pm
Edits made to:
Article (+16/-16 characters)

Article

ImStar Therapeutics is a biotechnology company developing treatments for neurodegenerative diseases. The company is headquartered in Vancouver, British ColumbiaBritish Columbia, Canada and was founded in 2012 by Daniel Wattier and Jean Pierre Julien.

Edits on 12 Dec 2018
Golden AI"Import data"
Golden AI edited on 12 Dec 2018 1:13 am
Edits made to:
Infobox (+2 properties)
Categories (+1 topics)
Edits on 9 Dec 2018
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 9 Dec 2018 2:42 am
Edits made to:
Article (+29/-29 characters)

Article

ImStar Therapeutics is developing treatments for neurodegenerative diseases such as Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis (ALS), Dementia, Alzheimer's Disease, and Parkinson's Disease. The company is using its unique research findings and understanding of a protein called TAR DNA-binding protein 43 (TDP-43) and its role in inflammatory responses to develop novel treatments for neurodegenerative diseases. 

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 8 Dec 2018 6:28 pm
Edits made to:
Article (+6/-6 characters)

Article

ImStar Therapeutics is a biotechnology company developing treatments for neurodegenerative diseases. The company is headquartered in Vancouver, British Columbia, CanadaCanada and was founded in 2012 by Daniel Wattier and Jean Pierre Julien.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 8 Dec 2018 6:27 pm
Edits made to:
Article (+9/-9 characters)

Article

ImStar Therapeutics is a biotechnology company developing treatments for neurodegenerative diseases. The company is headquartered in VancouverVancouver, British Columbia, Canada and was founded in 2012 by Daniel Wattier and Jean Pierre Julien.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 8 Dec 2018 6:26 pm
Edits made to:
Article (+8/-8 characters)

Article

ImStar Therapeutics is developing treatments for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), DementiaDementia, Alzheimer's Disease, and Parkinson's Disease. The company is using its unique research findings and understanding of a protein called TAR DNA-binding protein 43 (TDP-43) and its role in inflammatory responses to develop novel treatments for neurodegenerative diseases. 

Edits on 1 Dec 2018
Dawson Sewell
Dawson Sewell edited on 1 Dec 2018 5:49 pm
Edits made to:
Infobox (+2 properties)
Description (+109/-54 characters)
Article (+817 characters)
People (+10 cells) (+165/-7 characters)
Further reading (+8 cells) (+429 characters)
Categories (+1 topics)
Topic thumbnail

ImStar Therapeutics

A company transforming ALS & Neurodegenerative Disease

ImStar Therapeutics is company developing treatments for ALS, dementia, and other neurodegenerative diseases.

Article

ImStar Therapeutics is a biotechnology company developing treatments for neurodegenerative diseases. The company is headquartered in Vancouver, British Columbia, Canada and was founded in 2012 by Daniel Wattier and Jean Pierre Julien.



ImStar Therapeutics is developing treatments for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Dementia, Alzheimer's Disease, and Parkinson's Disease. The company is using its unique research findings and understanding of a protein called TAR DNA-binding protein 43 (TDP-43) and its role in inflammatory responses to develop novel treatments for neurodegenerative diseases. 

Funding

Seed Round

On June 8, 2016 ImStar Therapeutics closed their seed funding round with $1.8 million in funding from BDC Venture Capital and Accel-Rx Health Sciences Accelerator. 

People

Name
Role
Related Golden topics

Agnes Chan

COO



Daniel Wattier

FounderCo-Founder & CEO



David Hunt

Senior Vice President, Research and Development



Jean Pierre Julien

Co-Founder & CSO



Jeff Charpentier

CFO



Julia Levy

Board Chair



Further reading

Title
Author
Link
Type

ImStar Therapeutics Selects Lead Drug Candidate for ALS

ImStar Therapeutics

News

StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer

StemCells, Inc.

Web

Infobox

Categories

Edits on 19 Jul 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 Jul 2018 8:40 pm

Infobox

Location
Edits on 16 Jul 2018
Golden AI"Update markets in infobox"
Golden AI edited on 16 Jul 2018 11:31 pm

Infobox

Edits on 29 Jun 2018
Golden AI"Update infobox"
Golden AI edited on 29 Jun 2018 5:34 pm

Infobox

Edits on 18 Jun 2018
Golden AI"Updating description"
Golden AI edited on 18 Jun 2018 10:50 pm
Edits made to:
Description (+54/-21 characters)
Topic thumbnail

ImStar Therapeutics

Biotechnology company

A company transforming ALS & Neurodegenerative Disease

Edits on 30 May 2018
Golden AI"Initial topic creation"
Golden AI created this topic on 30 May 2018 10:31 pm
Edits made to:
Description (+21 characters)
People (+2 cells) (+21 characters)
Categories (+1 topics)
Topic thumbnail

 ImStar Therapeutics

Biotechnology company

People

Name
Role
Related Golden topics

Daniel Wattier

Founder



Categories

No more activity to show.